Highly Antifungal Activity of Biosynthesized Copper Oxide Nanoparticles against Candida albicans

Candida albicans (ATCC SC5314) was exposed to biosynthesized copper oxide nanoparticles (CuONPs) to determine their inhibitory capacity. Nanoparticles were polydisperse of small size (5.8 +/- 3.5 nm) with irregular shape. The minimum inhibitory concentration (MIC) against C. albicans was 35.5 mu g/mL. The production of reactive oxygen species (ROS) of C. albicans was verified when exposed to different concentrations of CuONPs. Ultrastructural analysis of C. albicans revealed a high concentration of CuONPs in the cytoplasm and outside the cell; also, nanoparticles were detected within the cell wall. Cytotoxic analyses using fibroblasts (L929), macrophages (RAW 264.7), and breast (MCF-12) cell lines show good results of cell viability when exposed at the MIC. Additionally, a hemocompatibility analysis was carried out and was found to be below 5%, considered the threshold for biocompatibility. Therefore, it is concluded that the biosynthesized CuONPs have a high potential for developing a topical antifungal treatment.

Automated summary

The biosynthesized copper oxide nanoparticles exhibit significant inhibitory effect on Candida albicans, showing potential as a candidate for developing topical antifungal treatment. Analysis reveals that exposure to nanoparticles leads to production of reactive oxygen species (ROS) in C. albicans, with nanoparticles distributed both inside and outside the cells, having minimal impact on cell viability.